Subependymal giant cell astrocytoma harboring a PRRC2B‐ALK fusion: A case report
Department of Neurosurgery, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan
Search for more papers by this authorCorresponding Author
Division of Brain Tumor Translational Research, National Cancer Center Research Institute, Tokyo, Japan
Correspondence
Yoshiko Nakano, Division of Brain Tumor Translational Research, National Cancer Center Research Institute, 5‐1‐1, Tsukiji, Chuo‐ku, Tokyo, 104‐0045 Japan.
Email yonakano@ncc.go.jp
Search for more papers by this authorDepartment of Pathology, Gunma University Hospital, Maebashi, Japan
Search for more papers by this authorDepartment of Diagnostic Pathology, National Cancer Center Hospital, Tokyo, Japan
Search for more papers by this authorDepartment of Neurosurgery, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan
Search for more papers by this authorDepartment of Neurosurgery, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan
Search for more papers by this authorDepartment of Neurosurgery, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan
Search for more papers by this authorDepartment of Neurosurgery, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan
Search for more papers by this authorDepartment of Neurosurgery, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan
Search for more papers by this authorDivision of Genome Biology, National Cancer Center Research Institute, Tokyo, Japan
Search for more papers by this authorDepartment of Pathology, National Center for Child Health and Development, Tokyo, Japan
Search for more papers by this authorDivision of Brain Tumor Translational Research, National Cancer Center Research Institute, Tokyo, Japan
Search for more papers by this authorDivision of Brain Tumor Translational Research, National Cancer Center Research Institute, Tokyo, Japan
Search for more papers by this authorDepartment of Neurosurgery, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan
Department of Neurosurgery, Yokohama City University, Yokohama, Japan
Search for more papers by this authorDepartment of Neurosurgery, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan
Search for more papers by this authorDepartment of Neurosurgery, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan
Search for more papers by this authorCorresponding Author
Division of Brain Tumor Translational Research, National Cancer Center Research Institute, Tokyo, Japan
Correspondence
Yoshiko Nakano, Division of Brain Tumor Translational Research, National Cancer Center Research Institute, 5‐1‐1, Tsukiji, Chuo‐ku, Tokyo, 104‐0045 Japan.
Email yonakano@ncc.go.jp
Search for more papers by this authorDepartment of Pathology, Gunma University Hospital, Maebashi, Japan
Search for more papers by this authorDepartment of Diagnostic Pathology, National Cancer Center Hospital, Tokyo, Japan
Search for more papers by this authorDepartment of Neurosurgery, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan
Search for more papers by this authorDepartment of Neurosurgery, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan
Search for more papers by this authorDepartment of Neurosurgery, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan
Search for more papers by this authorDepartment of Neurosurgery, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan
Search for more papers by this authorDepartment of Neurosurgery, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan
Search for more papers by this authorDivision of Genome Biology, National Cancer Center Research Institute, Tokyo, Japan
Search for more papers by this authorDepartment of Pathology, National Center for Child Health and Development, Tokyo, Japan
Search for more papers by this authorDivision of Brain Tumor Translational Research, National Cancer Center Research Institute, Tokyo, Japan
Search for more papers by this authorDivision of Brain Tumor Translational Research, National Cancer Center Research Institute, Tokyo, Japan
Search for more papers by this authorDepartment of Neurosurgery, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan
Department of Neurosurgery, Yokohama City University, Yokohama, Japan
Search for more papers by this authorDepartment of Neurosurgery, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan
Search for more papers by this authorFunding information:
Japan Children's Cancer Group (JCCG); Japan Agency for Medical Research and Development (AMED), Grant/Award Number: 16ck0106069h0003

Citing Literature
Supporting Information
| Filename | Description |
|---|---|
| pbc27995-sup-0001-FigureS1.tif261.1 KB | Supplementary Figure S1 Magnetic resonance imaging showing a heterogeneously enhanced, well‐demarcated tumor in the left lateral ventricle. The tumor is visualized with gadolinium‐enhanced T1‐weighted WI (A and D), T2‐weighted (B), diffusion‐weighted images (DWI) (C), and fluid‐attenuated inversion recovery (FLAIR) (E) images. |
| pbc27995-sup-0002-SuppMat1.docx21.3 KB | Supplementary information |
| pbc27995-sup-0003-SuppMat2.docx14.9 KB | Supplementary information |
Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.




